Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

EMA committee conditionally approves AbbVie leukemia drug

Saturday, October 15, 2016

AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency EMA on Friday for a drug to treat a form of blood cancer The tablet venclyxto or venetoclax is aimed at chronic lymphocytic leukemia CLL patients with e...

Lupin, Boehringer Ingelheim India to co-market diabetes drug Empagliflozin

Friday, October 14, 2016

Lupin Ltd type diabetes Boehringer Ingelheim India and Lupin announce strategic comarketing agreement Lupin Ltd says will market sell Empagliflozin under separate brand name Gibtulio Lupin Ltd says Boehringer will continue to sell Empagliflozin u...

Pfizer loses appeal in UK patent case over use of Lyrica drug for pain

Friday, October 14, 2016

Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a patent case over the use of its billionayear drug Lyrica for pain relief Pfizer said it was disappointed by the decision and would seek a furt...

Denmark's Genmab looks to immunotherapy for cancer drug encore

Friday, October 14, 2016

Immunotherapy which boosts the immune system to fight cancer could be the next big opportunity for Genmab potentially driving peak sales of its topselling drug well past billion a year its chief executive believes Shares in the Danish firm have sur...

Sun Pharma recalls 31,762 bottles of antidepressant drug in US

Thursday, October 13, 2016

Sun Pharmaceutical Industries is recalling bottles of bupropion hydrochloride extended release tablets used for treatment of major depressive disorder in the US due to failed dissolution specifications The recall has been initiated by Sun Pharmaceu...

Human Stem Cells Institute to develop ischemia drug in U.S. and Canada

Thursday, October 13, 2016

Human Stem Cells Institute Says it has licensed the exclusive US and Canadian rights for Neovasculgen to ArtGen Inc a privately held biotechnology company located in Rockville MD Neovasculgen is a firstinclass gene therapy drug that was approved in...

Synairgen slumps by a third as AstraZeneca ditches asthma drug study

Thursday, October 13, 2016

Synairgen Plc said its partner AstraZeneca Plc stopped a midstage study for testing Synairgens drug candidate as a potential treatment for severe asthma putting the brakes on the lead product in Synairgens pipeline The drug developers shares slumped...

RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc

Thursday, October 13, 2016

RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc RXi Pharmaceuticals Corp can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April RXi Pharmaceuticals Corp deal...

Addex Therapeutics initiates new study with US National Institute of Drug Abuse

Wednesday, October 12, 2016

Addex initiates new study in collaboration with US National Institute of Drug Abuse with ADX in nonhuman primate model of cocaine addiction Study is being conducted through companys ongoing research collaboration with US national institute of drug a...

Allergan says FDA accepts supplemental new drug application for avycaz

Wednesday, October 12, 2016

FDA accepts supplemental new drug application SNDA for avycaz ceftazidime and avibactam Allergan plc FDA is expected to take action on filing in q of Allergan application seeks to expand avycaz label to include phase clinical data for treatment...